JERUSALEM--(BUSINESS WIRE)--Mar. 5, 2015--
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio
webcast at the Barclays Global Healthcare Conference in Miami, FL. Eyal
Desheh, Group EVP & CFO will present on Thursday, March 12, 2015 at 8:30
AM ET.
|
What:
|
|
Teva Presentation at the Barclays Global Healthcare Conference
|
|
|
|
|
|
Who:
|
|
Eyal Desheh, Group EVP & CFO,
|
|
|
|
Teva Pharmaceutical Industries Ltd.
|
|
|
|
|
|
When:
|
|
Thursday, March 12, 2015
|
|
|
|
|
|
Where:
|
|
http://ir.tevapharm.com
|
|
|
|
|
|
How:
|
|
Live over the Internet – log on to the Web at the address above and
register for the event (approximately 10 minutes before). An archive
of the webcast will be available on Teva’s Website.
|
|
|
|
|
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading
global pharmaceutical company that delivers high-quality,
patient-centric healthcare solutions to millions of patients every day.
Headquartered in Israel, Teva is the world’s largest generic medicines
producer, leveraging its portfolio of more than 1,000 molecules to
produce a wide range of generic products in nearly every therapeutic
area. In specialty medicines, Teva has a world-leading position in
innovative treatments for disorders of the central nervous system,
including pain, as well as a strong portfolio of respiratory products.
Teva integrates its generics and specialty capabilities in its global
research and development division to create new ways of addressing unmet
patient needs by combining drug development capabilities with devices,
services and technologies. Teva's net revenues in 2014 amounted to $20.3
billion. For more information, visit www.tevapharm.com.
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR Contacts:
Kevin C.
Mannix, United States, 215-591-8912
Ran Meir, United
States, 215-591-3033
Tomer Amitai, Israel, 972 (3) 926-7656
or
PR Contacts:
Iris
Beck Codner, Israel, 972 (3) 926-7687
Denise Bradley, United
States, 215-591-8974